C07D 505/00
Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a
Official title: Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: [IMAGE cpc-sch-C07D-0995.gif] , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
C07D505/00 (Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a) appears on 191 US grants and 12 published applications in this corpus.
Search patents in C07D- Granted patents
- 191
- Published applications
- 12
- Assignees
- 40
- Inventors
- 209
- Latest grant
- 1 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 6 | 0 |
| 1980 | 13 | 0 |
| 1981 | 17 | 0 |
| 1982 | 9 | 0 |
| 1983 | 11 | 0 |
| 1984 | 9 | 0 |
| 1985 | 23 | 0 |
| 1986 | 12 | 0 |
| 1987 | 10 | 0 |
| 1988 | 2 | 0 |
| 1989 | 6 | 0 |
| 1990 | 7 | 0 |
| 1991 | 5 | 0 |
| 1992 | 6 | 0 |
| 1993 | 7 | 0 |
| 1994 | 2 | 0 |
| 1995 | 6 | 0 |
| 1996 | 5 | 0 |
| 1997 | 13 | 0 |
| 1998 | 5 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 2 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 2 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Refining method of midbody of latamoxef sodium1 Jul 2025US 12,344,622 B2Hainan Hailing Chemipharma Corporation Ltd.
- Method for manufacturing 7alpha-alkoxyoxacephem intermediate compound14 Jan 2020US 10,533,019 B2Dongdo Co., Ltd.
- 2 substituted cephem compounds8 Jan 2019US 10,174,053 B2Glaxo Group Limited
- Cephem compound having pyridinium group26 Jan 2016US 9,242,999 B2Shionogi & Co., Ltd.
- Cephalosporin having catechol group19 Jan 2016US 9,238,657 B2Shionogi & Co., Ltd.
- Refining method of midbody of latamoxef sodium8 Feb 2024US 2024/0043449 A1Hainan Hailing Chemipharma Corportion Ltd
- Method for manufacturing 7alpha-alkoxyoxacephem intermediate compound14 Mar 2019US 2019/0077812 A1Dongdo Co., Ltd.
- 2 substituted cephem compounds5 Oct 2017US 2017/0281532 A1Glaxo Group Limited
- 2-substituted cephem compounds22 Oct 2015US 2015/0299223 A1Glaxo Group Limited
- Cephem compound having pyridinium group24 Apr 2014US 2014/0114060 A1Shionogi & Co., Ltd.
Most cited
By later US patents
- Cephem derivative162US 4,278,793 AHoechst Aktiengesellschaft · 1981
- Fluorogenic substrates for .beta.-lactamase and methods of use85US 5,741,657 AThe Regents of the University of California · 1998
- Epimerization of malonic acid esters51US 4,504,658 AShionogi & Co., Ltd. · 1985
- Antimicrobial quinolonyl lactams38US 5,491,139 AThe Procter & Gamble Company · 1996
- Antimicrobial quinolonyl lactam esters34US 5,180,719 ANorwich Eaton Pharmaceuticals, Inc. · 1993